Healthcare provider profile · identity verified

Daryn N Mcclure, M.D.

Family Practice · QUEEN CREEK, AZ · NPI 1497827018

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	528	150
Levothyroxine Sodium	Levothyroxine Sodium	513	136
Amlodipine Besylate	Amlodipine Besylate	379	118
Rosuvastatin Calcium	Rosuvastatin Calcium	376	119
Pantoprazole Sodium	Pantoprazole Sodium	297	89
Metformin Hcl	Metformin Hcl	278	80
Losartan Potassium	Losartan Potassium	271	85
Lisinopril	Lisinopril	265	78
Gabapentin	Gabapentin	236	75
Metoprolol Succinate	Metoprolol Succinate	236	71
Hydrochlorothiazide	Hydrochlorothiazide	202	64
Trazodone Hcl	Trazodone Hcl	200	55
Tamsulosin Hcl	Tamsulosin Hcl	198	61
Furosemide	Furosemide	192	52
Sertraline Hcl	Sertraline Hcl	177	45
Omeprazole	Omeprazole	149	44
Simvastatin	Simvastatin	138	40
Carvedilol	Carvedilol	136	39
Mounjaro	Tirzepatide	130	26
Alendronate Sodium	Alendronate Sodium	129	42
Eliquis	Apixaban	126	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	124	34
Fluoxetine Hcl	Fluoxetine Hcl	121	40
Potassium Chloride	Potassium Chloride	118	32
Famotidine	Famotidine	114	35
Montelukast Sodium	Montelukast Sodium	111	33
Zolpidem Tartrate	Zolpidem Tartrate	111	30
Metoprolol Tartrate	Metoprolol Tartrate	110	30
Alprazolam	Alprazolam	101	17
Lorazepam	Lorazepam	94	25
Tramadol Hcl	Tramadol Hcl	94	28
Albuterol Sulfate Hfa	Albuterol Sulfate	90	36
Bupropion Xl	Bupropion Hcl	89	30
Clopidogrel	Clopidogrel Bisulfate	89	25
Celecoxib	Celecoxib	86	24
Prednisone	Prednisone	85	51
Quetiapine Fumarate	Quetiapine Fumarate	84	20
Pravastatin Sodium	Pravastatin Sodium	81	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	80	25
Pioglitazone Hcl	Pioglitazone Hcl	80	22
Atenolol	Atenolol	78	19
Escitalopram Oxalate	Escitalopram Oxalate	78	22
Cephalexin	Cephalexin	76	43
Allopurinol	Allopurinol	74	23
Duloxetine Hcl	Duloxetine Hcl	74	21
Fluticasone Propionate	Fluticasone Propionate	67	30
Fenofibrate	Fenofibrate	65	17
Olmesartan Medoxomil	Olmesartan Medoxomil	65	12
Citalopram Hbr	Citalopram Hydrobromide	64	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	60	18
Ozempic	Semaglutide	58	suppressed
Jardiance	Empagliflozin	57	15
Warfarin Sodium	Warfarin Sodium	53	17
Clonazepam	Clonazepam	51	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	21
Spironolactone	Spironolactone	48	13
Meloxicam	Meloxicam	47	16
Finasteride	Finasteride	46	14
Ropinirole Hcl	Ropinirole Hcl	46	13
Doxycycline Hyclate	Doxycycline Hyclate	45	27
Donepezil Hcl	Donepezil Hcl	43	11
Clonidine Hcl	Clonidine Hcl	42	13
Lovastatin	Lovastatin	41	12
Tizanidine Hcl	Tizanidine Hcl	41	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	40	16
Temazepam	Temazepam	40	suppressed
Metformin Hcl Er	Metformin Hcl	39	13
Glimepiride	Glimepiride	37	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	31
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	34	suppressed
Solifenacin Succinate	Solifenacin Succinate	33	12
Acyclovir	Acyclovir	32	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Lamotrigine	Lamotrigine	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	11
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Estradiol	Estradiol	27	suppressed
Glipizide	Glipizide	27	suppressed
Nystatin	Nystatin	27	12
Testosterone Cypionate	Testosterone Cypionate	27	13
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	26	11
Diazepam	Diazepam	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	24
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	22	suppressed
Methimazole	Methimazole	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Primidone	Primidone	20	suppressed
Risedronate Sodium	Risedronate Sodium	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Methocarbamol	Methocarbamol	19	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	18	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Linzess	Linaclotide	18	suppressed
Novolog	Insulin Aspart	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Topiramate	Topiramate	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	16	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Levofloxacin	Levofloxacin	16	12
Ondansetron Odt	Ondansetron	16	11
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Testosterone	Testosterone	15	suppressed
Anastrozole	Anastrozole	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Niacin Er	Niacin	14	suppressed
Risperidone	Risperidone	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Valsartan	Valsartan	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Thiothixene	Thiothixene	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error